New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 9, 2012
20:50 EDTMNOVMedicNova receives notice of patent allowance for asthma treatment
MediciNova announced that it has been granted a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, which covers the use of MN-221 for the treatment of acute exacerbations of asthma.
News For MNOV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
19:04 EDTMNOVMediciNova says CDC supports recruitment for clinical trial of MN-166
Subscribe for More Information
October 22, 2014
19:01 EDTMNOVMediciNova confirmsFDA granted orphan drug designation to MN-001
Subscribe for More Information
07:28 EDTMNOVNortheast Amyotrophic Lateral Sclerosis Consortium to hold annual meeting
Subscribe for More Information
October 21, 2014
18:05 EDTMNOVMediciNova granted orphan status for idiopathic pulmonary fibrosis drug
The FDA posted on its website that MediciNova has been granted orphan status for its treatment of idiopathic pulmonary fibrosis. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use